Breast Cancer Trial, Recruiting (NCT03417115)

Breast Cancer Trial, Recruiting NCT03417115 Sponsor: iOMEDICO AG Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03417115 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are a woman or man diagnosed with early-stage breast cancer (stage I–III, meaning the cancer has not spread beyond the breast or nearby underarm lymph nodes), and you are about to start your first systemic treatment (such as chemotherapy, hormone therapy, or targeted therapy)
You are a woman or man diagnosed with advanced breast cancer (stage IV, meaning the cancer has spread to other parts of the body), and you are about to start your first line of systemic treatment for advanced disease
You have been diagnosed with hormone receptor-positive, HER2-negative advanced breast cancer (stage IV) and started your first systemic treatment between September 2021 and December 2025 — this applies to a retrospective group, meaning you may be included even if your treatment already happened, and in some cases even if the patient has since passed away (confirm with trial site)
You are willing and able to sign a consent form agreeing to take part
If you are joining the patient-reported outcomes part of the study, you are able to complete a baseline questionnaire before starting your first treatment
If you are not joining the patient-reported outcomes part, you are able to enrol within six weeks of starting your first treatment

Who may not be able to join:

There are no specific exclusion criteria listed in the official trial information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03417115

Sponsor: iOMEDICO AG

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

More information: https://clinicaltrials.gov/study/NCT03417115

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are a woman or man diagnosed with early-stage breast cancer (stage I–III, meaning the cancer has not spread beyond the breast or nearby underarm lymph nodes), and you are about to start your first systemic treatment (such as chemotherapy, hormone therapy, or targeted therapy)
You are a woman or man diagnosed with advanced breast cancer (stage IV, meaning the cancer has spread to other parts of the body), and you are about to start your first line of systemic treatment for advanced disease
You have been diagnosed with hormone receptor-positive, HER2-negative advanced breast cancer (stage IV) and started your first systemic treatment between September 2021 and December 2025 — this applies to a retrospective group, meaning you may be included even if your treatment already happened, and in some cases even if the patient has since passed away (confirm with trial site)
You are willing and able to sign a consent form agreeing to take part
If you are joining the patient-reported outcomes part of the study, you are able to complete a baseline questionnaire before starting your first treatment
If you are not joining the patient-reported outcomes part, you are able to enrol within six weeks of starting your first treatment

Who may not be able to join:

There are no specific exclusion criteria listed in the official trial information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

iOMEDICO AG

Registry

ClinicalTrials.gov

Start date

22 December 2017

Est. completion

1 June 2032

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Treatment reality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov